Reaction

Substance Use Disorder reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,036 reports · 50 co-occurring drugs

As of the last recalculation, Substance Use Disorder appears in 3,036 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is ETHYL ALCOHOL (PRR 122.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ethyl Alcohol418122.2124.1
Isopropyl Alcohol41898.299.4
Alcohol41885.586.4
Oxazepam23480.881.6
Diazepam Oral Solution (Concentrate)66465.265.7
Diazepam Oral66465.265.7
Diazepam79059.860.2
Methadone Hydrochloride8958.158.5
Oxycodone And Acetaminophen Tablets8349.149.4
Amphetamine5344.745.0
Methadone23841.341.5
Oxycodone And Acetaminophen9428.528.6
Tramadol Hydrochloride13124.925.0
Buprenorphine29724.324.4
Pregabalin68121.821.9
Hydromorphone Hydrochloride24719.920.0
Sildenafil Powder,9819.519.5
Oxycodone Hydrochloride44116.116.1
Morphine Sulfate24515.015.0
Buprenorphine Hydrochloride, Naloxone Hydrochloride5014.414.5
Clonazepam30114.214.2
Aripiprazole Oral8314.114.1
Aripiprazole Orally Disintegrating8314.114.1
Morphine14614.014.1
Hydrocodone Bitartrate And Acetaminophen10713.513.5
Sildenafil10212.512.5
Oxycodone28811.611.6
Alprazolam28310.310.3
Methylphenidate419.89.8
Fentanyl1339.69.6
Naltrexone409.09.0
Oxycodone Hydrochloride And Acetaminophen1259.09.0
Methylphenidate Hydrochloride698.18.2
Paroxetine Hydrochloride Hemihydrate398.18.1
Paroxetine398.08.0
Quetiapine2087.97.9
Olanzapine1117.37.3
Venlafaxine727.07.0
Amitriptyline Hydrochloride176.76.7
Fentanyl Citrate176.66.6
Hydrocodone Bitartrate386.16.1
Sildenafil Citrate1086.06.0
Nicotine Polacrilex Mini136.06.0
Nicotine Polarilex136.06.0
Mirtazapine745.75.7
Acetaminophen And Codeine105.65.6
Zolpidem Tartrate1075.65.6
Aripiprazole915.25.2
Cannabidiol82.32.3
Esketamine Hydrochloride41.51.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.